NASDAQ: BRNS - Barinthus Biotherapeutics plc

Yield per half year: -26.06%
Dividend yield: 0.00%

Forward indicators

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
 0 0% 1.94 -100%
P/E Forward 0
P/S 0 0%
P/S Forward 0
P/BV 0 0%
P/BV Forward 0
Ev/Ebitda -0.08 0%
Ev/Ebitda Forward -0.1